Raw signal, scraped and timestamped.
Source material behind every call on the tape.
AnaptysBio ($ANAB) - biotech with key upcoming price catalysts
AnaptysBio (ANAB) isn’t your traditional biotech play. Essentially, it is a low-overhead royalty-management company formed around 2 drugs: Jemperli (partnered with GSK) and imsidolimab (partnered with Vanda Pharma). Here’s the relevant backstory. In 2014, ANAB signed a collaboration and exclusive …
19-year-old college student looking to invest for the long term. What would you buy in 2026?
Hey everyone, I’m 19 years old and currently in college. Right now I don’t have many expenses because my parents are helping pay for school and other necessities, so I’m trying to take advantage of this opportunity by investing as …
found the best trading record in congress, an 87% win rate over 118 trades, and the guy just resurfaced to buy SpaceX on IPO day
I've been scoring every member of Congress by how their disclosed trades actually played out, and one guy blows the rest away. John James (R-MI): 118 closed trades, 87% winners, roughly +22% average per trade. The members with a real …
Staking ADA on Robinhood. Love it
There's staking on Robinhood for ADA. Only a 1 day unlock period and only $1 minimum to stake and getting rewards in about 15 days Is there a better staking protocol out there in all honesty? I challenge people to …
[ Removed by moderator ]
[removed]
✅EMBC- The mistake of the Retail Investor is to rely entirely on AI. Setting her the wrong algorithms, thereby missing the most important moments. Which is not available for AI.‼️
One of the biggest mistakes many retail investors make is asking AI simple questions like: **“Is Embecta a good investment?”** or **“What’s wrong with EMBC?”** AI usually responds with a generic, surface-level summary based on the same headlines everyone has …